Site-specific labeling of annexin V with F-18 for apoptosis imaging

Bioconjugate Chemistry

Volumn 19, Issue 8, 2008, Pages 1684-1688

  Li, Xuehe ^a   Link, Jeanne M ^a   Stekhova, Svetlana ^a   Yagle, Kevin J ^a   Smith, Christina ^a   Krohn, Kenneth A ^a   Tait, Jonathan F ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BINDING ENERGY; CELL DEATH; IMAGE PROCESSING; REMOVAL;

ANNEXINS; APOPTOSIS IMAGING; APOPTOTIC CELLS; BINDING AFFINITIES; LABELINGS; MALEIMIDES; OUTER SURFACE; PHOSPHATIDYLSERINE; SINGLE CYSTEINE RESIDUE; SITE-SPECIFIC;

ANTIBIOTICS;

ANNEXIN V 128; ANNEXIN V 128 F 18; FLUORINE 18; LIPOCORTIN 5; MALEIMIDE DERIVATIVE; N [4 [(4 DIMETHYLAMINOBENZYLIDENE)AMINOOXYL]BUTYL]MALEIMIDE; N [4 [(4 FLUOROBENZYLIDENE F 18)AMINOOXY]BUTYL]MALEIMIDE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CHEMICAL MODIFICATION; DRUG CONJUGATION; DRUG PURIFICATION; DRUG SYNTHESIS; ERYTHROCYTE; IMAGING; ISOTOPE LABELING; MEMBRANE BINDING; ONE POT SYNTHESIS;

EID: 50249109496     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800164d     Document Type: Article

References (27)

1. Johnstone, R. W., Ruefli, A. A., and Lowe, S. W. (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153-164.
2. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., and Henson, P. M. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 146 (7), 2207-2216.
3. Martin, S. J., Reutelingsperger, C. P. M., McGahon, A. J., Rader, J. A., Van Schie, R. C. A. A., LaFace, D. M., and Grenn, D. R. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182, 1545-1556.
4. Thiagarajan, P., and Tait, J. F. (1990) Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J. Biol. Chem. 265, 17420-17423.
5. Lahorte, C. M. M., Vanderheyden, J.-L., Steinmetz, N., Van de Wiele, C., Dierckx, R. A., and Sledgers, G. (2004) Apoptois-detecting radioligands: current state of the art and future perspectives. Eur. J. Nucl. Med. Mol. Imaging 31, 887-919.
6. Blankenberg, F. G., Tait, J. F., and Strauss, H. W. (2000) Apoptotic cell death: its implications for imaging in the next millennium. Eur. J. Nucl. Med. 27, 359-367.
7. Blankenberg, F. G., Mari, C., and Strauss, H. W. (2003) Imaging cell death in vivo. Q. J. Nucl. Med. 47, 337-48.
8. Brauer, M. (2003) In vivo monitoring of apoptosis. Prog. Neuro Psychopharm. Biol. Psychiatry 27, 323-331.
9. 99mTc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin. Cancer Res. 8, 2766-2774.
10. Haas, R. L. M., De Jong, D., Olmos, R. A. V., Hoefnagel, C. A., van Heuvel, I. D., Zerp, S. F., Bartelink, H., and Verheij, M. (2004) In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Intl. J. Rad. Oncol. Biol. Phus. 59, 782-787.
11. 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. Radiother. Oncol. 72, 333-339.
12. Grierson, J. R., Yagle, K. J., Eary, J. F., Tait, J. F., Gibson, D. F., Lewellen, B., Link, J. M., and Krohn, K. A. (2004) Production of [F-18]fluoroannexin for imaging apoptosis with PET. Bioconjugate Chem. 15, 373-379.
13. Toretsky, J., Levenson, A., Weinberg, I. N., Tait, J. F., Uren, A., and Mease, R. C. (2004) Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death. Nucl. Med. Biol. 31, 747-752.
14. 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur. J. Nucl. Med. Mol. Imaging 31, 469-474.
15. 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J. Nucl. Med. 46, 658-666.
16. Tait, J. F., Smith, C., Levashova, Z., Patel, B., Blankenberg, F. G., and Vanderheyden, J.-L. (2006) Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods. J. Nucl. Med. 47, 1546-1553.
17. Brinkley, M. (1992) A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagent. Bioconjugate Chem. 3, 2-13.
18. Wilbur, D. S. (1992) Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjugate Chem. 3, 433-470.
19. 18F. J. Labelled Compd. Radiopharm. 26, 287-289.
20. 18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. Bioconjugate Chem. 16, 406-420.
21. 18F-labeling agent. Bioconjugate Chem. 14, 1253-1259.
22. Tait, J. F., Gibson, D. F., and Smith, C. (2004) Measurement of the affinity and cooperativity of annexin V-membrane binding under conditions of low membrane occupancy. Anal. Biochem. 329, 112-119.
23. 18F]fluorobenzyndene)aminooxyhexyl]maleimide. Nucl. Med. Biol. 34, 5-15.
24. 18F]GBR-13119. J. Labelled Compd. Radiopharm. 27, 823-833.
25. 18F]-fluorodexetimides. J. Labeled Compd. Radiopharm. 28, 1189-1199.
26. Jin, M., Smith, C., Hsieh, H.-Y., Gibson, D. F., and Tait, J. F. (2004) Essential role of B-helix calcium binding sites in annexin V-memberane binding. J. Biol. Chem. 279, 40351-40357.
27. Tait, J. F., and Gibson, D. (1994) Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J. Lab. Clin. Med 123 (5), 741-748.